LAUSR

ABSTRACT Introduction Autophagy is a highly conservative self-degradative process. It aims at elimination-impaired proteins and cellular organelles. Previous research confirmed the autophagy role in cancer pathogenesis. Areas covered This article discusses the role of autophagy in the development of AML. Autophagy seems to be a ‘double-sword’ mechanism, hence, either its suppression or induction could promote neoplasm growth. This mechanism could also be the aim of the ‘molecular targeted therapy.’ Chemo- and radiotherapy induce cellular stress in neoplasm cells with subsequent autophagy suppression. Simultaneously, it is claimed that the autophagy suppression increases chemosensitivity ’in neoplastic cells. Some agents, like bortezomib, in turn could promote autophagy process, e.g. in AML (acute myeloid leukemia). However, currently there are not many studies focusing on the role of autophagy in patients suffering for AML. In this review, we summarize the research done so far on the role of autophagy in the development of AML. Expert opinion The analysis of autophagy genes expression profiling in AML could be a relevant factor in the diagnostic process and treatment ‘individualization.’ Autophagy modulation seems to be a relevant target in the oncological therapy – it could limit disease progression and increase the effectiveness of treatment.